A Phase III, Randomized, Double-blind, Multi-center Clinical Trial Comparing the Safety and Efficacy of Veronate® Versus Placebo for the Prevention of Nosocomial Staphylococcal Sepsis in Premature Infants (Birth Weight 500 - 1250 g).
Phase of Trial: Phase III
Latest Information Update: 01 Aug 2012
At a glance
- Drugs INH A21 (Primary)
- Indications Bacteraemia; Nosocomial infections; Sepsis; Staphylococcal infections
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 25 Jan 2006 New trial record.